Compare LTH & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTH | ITGR |
|---|---|---|
| Founded | 1992 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 2.6B |
| IPO Year | 2021 | 2000 |
| Metric | LTH | ITGR |
|---|---|---|
| Price | $26.45 | $78.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $37.50 | ★ $95.00 |
| AVG Volume (30 Days) | ★ 2.0M | 611.6K |
| Earning Date | 11-04-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.46 | N/A |
| EPS | 1.28 | ★ 2.42 |
| Revenue | ★ $2,913,442,000.00 | $1,831,074,000.00 |
| Revenue This Year | $15.07 | $9.58 |
| Revenue Next Year | $10.88 | N/A |
| P/E Ratio | ★ $20.58 | $32.38 |
| Revenue Growth | ★ 15.77 | 9.54 |
| 52 Week Low | $21.49 | $62.00 |
| 52 Week High | $34.99 | $146.36 |
| Indicator | LTH | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 63.07 |
| Support Level | $25.60 | $72.17 |
| Resistance Level | $26.73 | $80.95 |
| Average True Range (ATR) | 0.59 | 1.86 |
| MACD | 0.00 | 1.30 |
| Stochastic Oscillator | 49.34 | 72.49 |
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.